Genmab — Januar 2020
-
Ser da meget godt ud fra TA synspunkt. Søger op mod / over de 1700 i løbet af Februar https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81268_Jan_30_2020.JPG
-
Genmabs nye indtægtskilde Horizon køber amerikansk hovedkvarter af Takeda
Horizon Therapeutics, der for nylig har fået godkendt det tidligere Genmab-middel Tepezza hos FDA, gør nu plads til en større udvidelse i USA.
(medwatch.dk)
-
Dara on the agenda of the EMA Paediatric Committee (PDCO). Only reveals it has to do with Systemic light chain amyloidosis https://www.ema.europa.eu/en/documents/agenda/agenda-pdco-agenda-28-31-january-2020-meeting_en.pdf
-
De får 4 gange så meget plads https://patch.com/illinois/deerfield/horizon-buying-vacant-former-takeda-headquarters-deerfield
-
Det ved vi 17.00..;-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
